The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

21 Mar 2018 07:00

RNS Number : 3549I
Impellam Group plc
21 March 2018
 

21 March 2018

Impellam Group plc

("Impellam" or the "Company")

 

Transaction in Own Shares and Total Voting Rights

 

Further to its announcement on 18 December 2017, the Company announces that it has made (through Cenkos Securities plc acting as its broker) the following purchase of its own ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") for cancellation in accordance with the Share Purchase Plan.

 

Date of purchase:

20 March 2018

Number of Ordinary Shares purchased (aggregated volume):

13,200

Price paid per Ordinary Share (pence):

566.5

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

 

Following the above purchase and subsequent cancellation, the Company will have 50,290,421 Ordinary Shares in issue. This figure of 50,290,421 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Impellam Group plc

 

Julia Robertson, Chief Executive Officer 01582 692658

Alison Wilford, Chief Financial Officer 

 

Cenkos Securities plc (Nomad and Corporate broker)

 

Nicholas Wells / Mark Connelly 020 7397 8900

 

Note to Editors:

Impellam is the second largest1 staffing business in the UK and sixth largest2 Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 18 market-leading brands across 168 worldwide locations.

 

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit: www.impellam.com

 

1 By revenue (2016 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Service brands manage on behalf of their clients whether acting as a principal or agent. Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSSEWFWSFASEFD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.